Harmony Medical Transitions Llc - Medicare Primary Care in Alexandria, VA

Harmony Medical Transitions Llc is a medicare enrolled primary clinic (Internal Medicine) in Alexandria, Virginia. The current practice location for Harmony Medical Transitions Llc is 2729 King St, Alexandria, Virginia. For appointments, you can reach them via phone at (571) 685-2015. The mailing address for Harmony Medical Transitions Llc is 3114 Patrick Henry Dr, Falls Church, Virginia and phone number is (703) 705-9500.

Harmony Medical Transitions Llc is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1639840952. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (571) 685-2015.

Contact Information

Harmony Medical Transitions Llc
2729 King St
Alexandria
VA 22302-4008
(571) 685-2015
(571) 685-2016

Primary Care Clinic Profile

Full NameHarmony Medical Transitions Llc
SpecialityInternal Medicine
Location2729 King St, Alexandria, Virginia
Authorized Official Name and PositionAhmed Elebiary (SOLE OWNER)
Authorized Official Contact7037059500
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Harmony Medical Transitions Llc
3114 Patrick Henry Dr
Falls Church
VA 22044-1823

Ph: (703) 705-9500
Harmony Medical Transitions Llc
2729 King St
Alexandria
VA 22302-4008

Ph: (571) 685-2015

NPI Details:

NPI Number1639840952
Provider Enumeration Date09/27/2021
Last Update Date01/01/2024

Medicare PECOS Information:

Medicare PECOS PAC ID2567860463
Medicare Enrollment IDO20211007000133

News Archive

Researchers present unique program aimed at HIV prevention in runaway youth

Researchers at Wake Forest University Baptist Medical Center are the first in the U.S. to develop an HIV prevention and intervention program for adolescent runaways that focuses on their strengths.

NIH-funded program to focus on obesity complications in low-income mothers

A Michigan State University nursing researcher has been awarded $3.3 million to help low-income mothers who are overweight or obese improve their health by eating well, being active and dealing with stress.

Study shows children and adults have a comparable expression of SARS-CoV-2 entry-related genes

A recent paper by researchers from China demonstrated comparable expression levels of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cell entry mediators in adults and children, suggesting that previously implied difference in viral-entry associated genes is likely not responsible for milder symptoms in children. The study is currently available on the medRxiv preprint server.

New data from Acucela's ACU-4429 Phase 2a trial on advanced dry AMD/geographic atrophy

Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that the first patient data from the ACU-4429 program were presented during a poster session at The Association for Research in Vision and Ophthalmology (ARVO) 2012 Annual Meeting.

Researchers demonstrate potential of new PET tracer for imaging prostate cancer

In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the University of Michigan demonstrate the potential of a new PET tracer, Carbon-11 labeled sarcosine (11C-sarcosine), for imaging prostate cancer, and set the stage for its possible use in monitoring other cancers.

Read more Medical News

› Verified 6 days ago

Medical Identifiers

Medical identifiers for Harmony Medical Transitions Llc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1639840952NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207R00000XInternal Medicine (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Harmony Medical Transitions Llc acts as a billing entity for following providers:
Provider NameSapna Sharma
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1982903829
PECOS PAC ID: 9335317486
Enrollment ID: I20130827000868

News Archive

Researchers present unique program aimed at HIV prevention in runaway youth

Researchers at Wake Forest University Baptist Medical Center are the first in the U.S. to develop an HIV prevention and intervention program for adolescent runaways that focuses on their strengths.

NIH-funded program to focus on obesity complications in low-income mothers

A Michigan State University nursing researcher has been awarded $3.3 million to help low-income mothers who are overweight or obese improve their health by eating well, being active and dealing with stress.

Study shows children and adults have a comparable expression of SARS-CoV-2 entry-related genes

A recent paper by researchers from China demonstrated comparable expression levels of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cell entry mediators in adults and children, suggesting that previously implied difference in viral-entry associated genes is likely not responsible for milder symptoms in children. The study is currently available on the medRxiv preprint server.

New data from Acucela's ACU-4429 Phase 2a trial on advanced dry AMD/geographic atrophy

Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that the first patient data from the ACU-4429 program were presented during a poster session at The Association for Research in Vision and Ophthalmology (ARVO) 2012 Annual Meeting.

Researchers demonstrate potential of new PET tracer for imaging prostate cancer

In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the University of Michigan demonstrate the potential of a new PET tracer, Carbon-11 labeled sarcosine (11C-sarcosine), for imaging prostate cancer, and set the stage for its possible use in monitoring other cancers.

Read more Medical News

› Verified 6 days ago

Provider NameAhmed Mahmoud Elebiary
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1659719227
PECOS PAC ID: 8022301704
Enrollment ID: I20160809000083

News Archive

Researchers present unique program aimed at HIV prevention in runaway youth

Researchers at Wake Forest University Baptist Medical Center are the first in the U.S. to develop an HIV prevention and intervention program for adolescent runaways that focuses on their strengths.

NIH-funded program to focus on obesity complications in low-income mothers

A Michigan State University nursing researcher has been awarded $3.3 million to help low-income mothers who are overweight or obese improve their health by eating well, being active and dealing with stress.

Study shows children and adults have a comparable expression of SARS-CoV-2 entry-related genes

A recent paper by researchers from China demonstrated comparable expression levels of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cell entry mediators in adults and children, suggesting that previously implied difference in viral-entry associated genes is likely not responsible for milder symptoms in children. The study is currently available on the medRxiv preprint server.

New data from Acucela's ACU-4429 Phase 2a trial on advanced dry AMD/geographic atrophy

Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that the first patient data from the ACU-4429 program were presented during a poster session at The Association for Research in Vision and Ophthalmology (ARVO) 2012 Annual Meeting.

Researchers demonstrate potential of new PET tracer for imaging prostate cancer

In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the University of Michigan demonstrate the potential of a new PET tracer, Carbon-11 labeled sarcosine (11C-sarcosine), for imaging prostate cancer, and set the stage for its possible use in monitoring other cancers.

Read more Medical News

› Verified 6 days ago

Provider NameMustafa Rikabi
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1588077697
PECOS PAC ID: 8820370950
Enrollment ID: I20190923002281

News Archive

Researchers present unique program aimed at HIV prevention in runaway youth

Researchers at Wake Forest University Baptist Medical Center are the first in the U.S. to develop an HIV prevention and intervention program for adolescent runaways that focuses on their strengths.

NIH-funded program to focus on obesity complications in low-income mothers

A Michigan State University nursing researcher has been awarded $3.3 million to help low-income mothers who are overweight or obese improve their health by eating well, being active and dealing with stress.

Study shows children and adults have a comparable expression of SARS-CoV-2 entry-related genes

A recent paper by researchers from China demonstrated comparable expression levels of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cell entry mediators in adults and children, suggesting that previously implied difference in viral-entry associated genes is likely not responsible for milder symptoms in children. The study is currently available on the medRxiv preprint server.

New data from Acucela's ACU-4429 Phase 2a trial on advanced dry AMD/geographic atrophy

Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that the first patient data from the ACU-4429 program were presented during a poster session at The Association for Research in Vision and Ophthalmology (ARVO) 2012 Annual Meeting.

Researchers demonstrate potential of new PET tracer for imaging prostate cancer

In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the University of Michigan demonstrate the potential of a new PET tracer, Carbon-11 labeled sarcosine (11C-sarcosine), for imaging prostate cancer, and set the stage for its possible use in monitoring other cancers.

Read more Medical News

› Verified 6 days ago

Provider NameMargaret Lefah Mbinyi
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1104380716
PECOS PAC ID: 9537574330
Enrollment ID: I20210208002284

News Archive

Researchers present unique program aimed at HIV prevention in runaway youth

Researchers at Wake Forest University Baptist Medical Center are the first in the U.S. to develop an HIV prevention and intervention program for adolescent runaways that focuses on their strengths.

NIH-funded program to focus on obesity complications in low-income mothers

A Michigan State University nursing researcher has been awarded $3.3 million to help low-income mothers who are overweight or obese improve their health by eating well, being active and dealing with stress.

Study shows children and adults have a comparable expression of SARS-CoV-2 entry-related genes

A recent paper by researchers from China demonstrated comparable expression levels of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cell entry mediators in adults and children, suggesting that previously implied difference in viral-entry associated genes is likely not responsible for milder symptoms in children. The study is currently available on the medRxiv preprint server.

New data from Acucela's ACU-4429 Phase 2a trial on advanced dry AMD/geographic atrophy

Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that the first patient data from the ACU-4429 program were presented during a poster session at The Association for Research in Vision and Ophthalmology (ARVO) 2012 Annual Meeting.

Researchers demonstrate potential of new PET tracer for imaging prostate cancer

In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the University of Michigan demonstrate the potential of a new PET tracer, Carbon-11 labeled sarcosine (11C-sarcosine), for imaging prostate cancer, and set the stage for its possible use in monitoring other cancers.

Read more Medical News

› Verified 6 days ago

Provider NameYael E Daniel
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1164029823
PECOS PAC ID: 0345655544
Enrollment ID: I20210222001691

News Archive

Researchers present unique program aimed at HIV prevention in runaway youth

Researchers at Wake Forest University Baptist Medical Center are the first in the U.S. to develop an HIV prevention and intervention program for adolescent runaways that focuses on their strengths.

NIH-funded program to focus on obesity complications in low-income mothers

A Michigan State University nursing researcher has been awarded $3.3 million to help low-income mothers who are overweight or obese improve their health by eating well, being active and dealing with stress.

Study shows children and adults have a comparable expression of SARS-CoV-2 entry-related genes

A recent paper by researchers from China demonstrated comparable expression levels of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cell entry mediators in adults and children, suggesting that previously implied difference in viral-entry associated genes is likely not responsible for milder symptoms in children. The study is currently available on the medRxiv preprint server.

New data from Acucela's ACU-4429 Phase 2a trial on advanced dry AMD/geographic atrophy

Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that the first patient data from the ACU-4429 program were presented during a poster session at The Association for Research in Vision and Ophthalmology (ARVO) 2012 Annual Meeting.

Researchers demonstrate potential of new PET tracer for imaging prostate cancer

In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the University of Michigan demonstrate the potential of a new PET tracer, Carbon-11 labeled sarcosine (11C-sarcosine), for imaging prostate cancer, and set the stage for its possible use in monitoring other cancers.

Read more Medical News

› Verified 6 days ago

Provider NameDa Eun Kim Yun
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1548847213
PECOS PAC ID: 3577971753
Enrollment ID: I20210428001773

News Archive

Researchers present unique program aimed at HIV prevention in runaway youth

Researchers at Wake Forest University Baptist Medical Center are the first in the U.S. to develop an HIV prevention and intervention program for adolescent runaways that focuses on their strengths.

NIH-funded program to focus on obesity complications in low-income mothers

A Michigan State University nursing researcher has been awarded $3.3 million to help low-income mothers who are overweight or obese improve their health by eating well, being active and dealing with stress.

Study shows children and adults have a comparable expression of SARS-CoV-2 entry-related genes

A recent paper by researchers from China demonstrated comparable expression levels of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cell entry mediators in adults and children, suggesting that previously implied difference in viral-entry associated genes is likely not responsible for milder symptoms in children. The study is currently available on the medRxiv preprint server.

New data from Acucela's ACU-4429 Phase 2a trial on advanced dry AMD/geographic atrophy

Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that the first patient data from the ACU-4429 program were presented during a poster session at The Association for Research in Vision and Ophthalmology (ARVO) 2012 Annual Meeting.

Researchers demonstrate potential of new PET tracer for imaging prostate cancer

In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the University of Michigan demonstrate the potential of a new PET tracer, Carbon-11 labeled sarcosine (11C-sarcosine), for imaging prostate cancer, and set the stage for its possible use in monitoring other cancers.

Read more Medical News

› Verified 6 days ago

Provider NameSainabou Jallow
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1013510619
PECOS PAC ID: 6204235096
Enrollment ID: I20210527001531

News Archive

Researchers present unique program aimed at HIV prevention in runaway youth

Researchers at Wake Forest University Baptist Medical Center are the first in the U.S. to develop an HIV prevention and intervention program for adolescent runaways that focuses on their strengths.

NIH-funded program to focus on obesity complications in low-income mothers

A Michigan State University nursing researcher has been awarded $3.3 million to help low-income mothers who are overweight or obese improve their health by eating well, being active and dealing with stress.

Study shows children and adults have a comparable expression of SARS-CoV-2 entry-related genes

A recent paper by researchers from China demonstrated comparable expression levels of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cell entry mediators in adults and children, suggesting that previously implied difference in viral-entry associated genes is likely not responsible for milder symptoms in children. The study is currently available on the medRxiv preprint server.

New data from Acucela's ACU-4429 Phase 2a trial on advanced dry AMD/geographic atrophy

Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that the first patient data from the ACU-4429 program were presented during a poster session at The Association for Research in Vision and Ophthalmology (ARVO) 2012 Annual Meeting.

Researchers demonstrate potential of new PET tracer for imaging prostate cancer

In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the University of Michigan demonstrate the potential of a new PET tracer, Carbon-11 labeled sarcosine (11C-sarcosine), for imaging prostate cancer, and set the stage for its possible use in monitoring other cancers.

Read more Medical News

› Verified 6 days ago

Provider NameTsige W Sorga
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1376157560
PECOS PAC ID: 8820403108
Enrollment ID: I20210914000977

News Archive

Researchers present unique program aimed at HIV prevention in runaway youth

Researchers at Wake Forest University Baptist Medical Center are the first in the U.S. to develop an HIV prevention and intervention program for adolescent runaways that focuses on their strengths.

NIH-funded program to focus on obesity complications in low-income mothers

A Michigan State University nursing researcher has been awarded $3.3 million to help low-income mothers who are overweight or obese improve their health by eating well, being active and dealing with stress.

Study shows children and adults have a comparable expression of SARS-CoV-2 entry-related genes

A recent paper by researchers from China demonstrated comparable expression levels of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cell entry mediators in adults and children, suggesting that previously implied difference in viral-entry associated genes is likely not responsible for milder symptoms in children. The study is currently available on the medRxiv preprint server.

New data from Acucela's ACU-4429 Phase 2a trial on advanced dry AMD/geographic atrophy

Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that the first patient data from the ACU-4429 program were presented during a poster session at The Association for Research in Vision and Ophthalmology (ARVO) 2012 Annual Meeting.

Researchers demonstrate potential of new PET tracer for imaging prostate cancer

In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the University of Michigan demonstrate the potential of a new PET tracer, Carbon-11 labeled sarcosine (11C-sarcosine), for imaging prostate cancer, and set the stage for its possible use in monitoring other cancers.

Read more Medical News

› Verified 6 days ago

Provider NameKiara Pegues
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1174132500
PECOS PAC ID: 3274930284
Enrollment ID: I20210917001139

News Archive

Researchers present unique program aimed at HIV prevention in runaway youth

Researchers at Wake Forest University Baptist Medical Center are the first in the U.S. to develop an HIV prevention and intervention program for adolescent runaways that focuses on their strengths.

NIH-funded program to focus on obesity complications in low-income mothers

A Michigan State University nursing researcher has been awarded $3.3 million to help low-income mothers who are overweight or obese improve their health by eating well, being active and dealing with stress.

Study shows children and adults have a comparable expression of SARS-CoV-2 entry-related genes

A recent paper by researchers from China demonstrated comparable expression levels of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cell entry mediators in adults and children, suggesting that previously implied difference in viral-entry associated genes is likely not responsible for milder symptoms in children. The study is currently available on the medRxiv preprint server.

New data from Acucela's ACU-4429 Phase 2a trial on advanced dry AMD/geographic atrophy

Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that the first patient data from the ACU-4429 program were presented during a poster session at The Association for Research in Vision and Ophthalmology (ARVO) 2012 Annual Meeting.

Researchers demonstrate potential of new PET tracer for imaging prostate cancer

In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the University of Michigan demonstrate the potential of a new PET tracer, Carbon-11 labeled sarcosine (11C-sarcosine), for imaging prostate cancer, and set the stage for its possible use in monitoring other cancers.

Read more Medical News

› Verified 6 days ago

Provider NameMariatu Turay
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1134881758
PECOS PAC ID: 6406244243
Enrollment ID: I20211027000773

News Archive

Researchers present unique program aimed at HIV prevention in runaway youth

Researchers at Wake Forest University Baptist Medical Center are the first in the U.S. to develop an HIV prevention and intervention program for adolescent runaways that focuses on their strengths.

NIH-funded program to focus on obesity complications in low-income mothers

A Michigan State University nursing researcher has been awarded $3.3 million to help low-income mothers who are overweight or obese improve their health by eating well, being active and dealing with stress.

Study shows children and adults have a comparable expression of SARS-CoV-2 entry-related genes

A recent paper by researchers from China demonstrated comparable expression levels of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cell entry mediators in adults and children, suggesting that previously implied difference in viral-entry associated genes is likely not responsible for milder symptoms in children. The study is currently available on the medRxiv preprint server.

New data from Acucela's ACU-4429 Phase 2a trial on advanced dry AMD/geographic atrophy

Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that the first patient data from the ACU-4429 program were presented during a poster session at The Association for Research in Vision and Ophthalmology (ARVO) 2012 Annual Meeting.

Researchers demonstrate potential of new PET tracer for imaging prostate cancer

In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the University of Michigan demonstrate the potential of a new PET tracer, Carbon-11 labeled sarcosine (11C-sarcosine), for imaging prostate cancer, and set the stage for its possible use in monitoring other cancers.

Read more Medical News

› Verified 6 days ago

Provider NameFranco Porto
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1366107112
PECOS PAC ID: 1658761697
Enrollment ID: I20211206001091

News Archive

Researchers present unique program aimed at HIV prevention in runaway youth

Researchers at Wake Forest University Baptist Medical Center are the first in the U.S. to develop an HIV prevention and intervention program for adolescent runaways that focuses on their strengths.

NIH-funded program to focus on obesity complications in low-income mothers

A Michigan State University nursing researcher has been awarded $3.3 million to help low-income mothers who are overweight or obese improve their health by eating well, being active and dealing with stress.

Study shows children and adults have a comparable expression of SARS-CoV-2 entry-related genes

A recent paper by researchers from China demonstrated comparable expression levels of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cell entry mediators in adults and children, suggesting that previously implied difference in viral-entry associated genes is likely not responsible for milder symptoms in children. The study is currently available on the medRxiv preprint server.

New data from Acucela's ACU-4429 Phase 2a trial on advanced dry AMD/geographic atrophy

Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that the first patient data from the ACU-4429 program were presented during a poster session at The Association for Research in Vision and Ophthalmology (ARVO) 2012 Annual Meeting.

Researchers demonstrate potential of new PET tracer for imaging prostate cancer

In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the University of Michigan demonstrate the potential of a new PET tracer, Carbon-11 labeled sarcosine (11C-sarcosine), for imaging prostate cancer, and set the stage for its possible use in monitoring other cancers.

Read more Medical News

› Verified 6 days ago

Provider NameDinesh Lama
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1801567490
PECOS PAC ID: 5698166551
Enrollment ID: I20220103001995

News Archive

Researchers present unique program aimed at HIV prevention in runaway youth

Researchers at Wake Forest University Baptist Medical Center are the first in the U.S. to develop an HIV prevention and intervention program for adolescent runaways that focuses on their strengths.

NIH-funded program to focus on obesity complications in low-income mothers

A Michigan State University nursing researcher has been awarded $3.3 million to help low-income mothers who are overweight or obese improve their health by eating well, being active and dealing with stress.

Study shows children and adults have a comparable expression of SARS-CoV-2 entry-related genes

A recent paper by researchers from China demonstrated comparable expression levels of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cell entry mediators in adults and children, suggesting that previously implied difference in viral-entry associated genes is likely not responsible for milder symptoms in children. The study is currently available on the medRxiv preprint server.

New data from Acucela's ACU-4429 Phase 2a trial on advanced dry AMD/geographic atrophy

Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that the first patient data from the ACU-4429 program were presented during a poster session at The Association for Research in Vision and Ophthalmology (ARVO) 2012 Annual Meeting.

Researchers demonstrate potential of new PET tracer for imaging prostate cancer

In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the University of Michigan demonstrate the potential of a new PET tracer, Carbon-11 labeled sarcosine (11C-sarcosine), for imaging prostate cancer, and set the stage for its possible use in monitoring other cancers.

Read more Medical News

› Verified 6 days ago

Provider NameHawa Senesie
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1881275451
PECOS PAC ID: 4284013707
Enrollment ID: I20220614000177

News Archive

Researchers present unique program aimed at HIV prevention in runaway youth

Researchers at Wake Forest University Baptist Medical Center are the first in the U.S. to develop an HIV prevention and intervention program for adolescent runaways that focuses on their strengths.

NIH-funded program to focus on obesity complications in low-income mothers

A Michigan State University nursing researcher has been awarded $3.3 million to help low-income mothers who are overweight or obese improve their health by eating well, being active and dealing with stress.

Study shows children and adults have a comparable expression of SARS-CoV-2 entry-related genes

A recent paper by researchers from China demonstrated comparable expression levels of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cell entry mediators in adults and children, suggesting that previously implied difference in viral-entry associated genes is likely not responsible for milder symptoms in children. The study is currently available on the medRxiv preprint server.

New data from Acucela's ACU-4429 Phase 2a trial on advanced dry AMD/geographic atrophy

Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that the first patient data from the ACU-4429 program were presented during a poster session at The Association for Research in Vision and Ophthalmology (ARVO) 2012 Annual Meeting.

Researchers demonstrate potential of new PET tracer for imaging prostate cancer

In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the University of Michigan demonstrate the potential of a new PET tracer, Carbon-11 labeled sarcosine (11C-sarcosine), for imaging prostate cancer, and set the stage for its possible use in monitoring other cancers.

Read more Medical News

› Verified 6 days ago

Provider NameToyin Mary Ajayi
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1811560279
PECOS PAC ID: 6800260845
Enrollment ID: I20230315000360

News Archive

Researchers present unique program aimed at HIV prevention in runaway youth

Researchers at Wake Forest University Baptist Medical Center are the first in the U.S. to develop an HIV prevention and intervention program for adolescent runaways that focuses on their strengths.

NIH-funded program to focus on obesity complications in low-income mothers

A Michigan State University nursing researcher has been awarded $3.3 million to help low-income mothers who are overweight or obese improve their health by eating well, being active and dealing with stress.

Study shows children and adults have a comparable expression of SARS-CoV-2 entry-related genes

A recent paper by researchers from China demonstrated comparable expression levels of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cell entry mediators in adults and children, suggesting that previously implied difference in viral-entry associated genes is likely not responsible for milder symptoms in children. The study is currently available on the medRxiv preprint server.

New data from Acucela's ACU-4429 Phase 2a trial on advanced dry AMD/geographic atrophy

Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that the first patient data from the ACU-4429 program were presented during a poster session at The Association for Research in Vision and Ophthalmology (ARVO) 2012 Annual Meeting.

Researchers demonstrate potential of new PET tracer for imaging prostate cancer

In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the University of Michigan demonstrate the potential of a new PET tracer, Carbon-11 labeled sarcosine (11C-sarcosine), for imaging prostate cancer, and set the stage for its possible use in monitoring other cancers.

Read more Medical News

› Verified 6 days ago

Provider NameNzigire Matali
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1487366738
PECOS PAC ID: 9032584206
Enrollment ID: I20230331002645

News Archive

Researchers present unique program aimed at HIV prevention in runaway youth

Researchers at Wake Forest University Baptist Medical Center are the first in the U.S. to develop an HIV prevention and intervention program for adolescent runaways that focuses on their strengths.

NIH-funded program to focus on obesity complications in low-income mothers

A Michigan State University nursing researcher has been awarded $3.3 million to help low-income mothers who are overweight or obese improve their health by eating well, being active and dealing with stress.

Study shows children and adults have a comparable expression of SARS-CoV-2 entry-related genes

A recent paper by researchers from China demonstrated comparable expression levels of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cell entry mediators in adults and children, suggesting that previously implied difference in viral-entry associated genes is likely not responsible for milder symptoms in children. The study is currently available on the medRxiv preprint server.

New data from Acucela's ACU-4429 Phase 2a trial on advanced dry AMD/geographic atrophy

Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that the first patient data from the ACU-4429 program were presented during a poster session at The Association for Research in Vision and Ophthalmology (ARVO) 2012 Annual Meeting.

Researchers demonstrate potential of new PET tracer for imaging prostate cancer

In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the University of Michigan demonstrate the potential of a new PET tracer, Carbon-11 labeled sarcosine (11C-sarcosine), for imaging prostate cancer, and set the stage for its possible use in monitoring other cancers.

Read more Medical News

› Verified 6 days ago

News Archive

Researchers present unique program aimed at HIV prevention in runaway youth

Researchers at Wake Forest University Baptist Medical Center are the first in the U.S. to develop an HIV prevention and intervention program for adolescent runaways that focuses on their strengths.

NIH-funded program to focus on obesity complications in low-income mothers

A Michigan State University nursing researcher has been awarded $3.3 million to help low-income mothers who are overweight or obese improve their health by eating well, being active and dealing with stress.

Study shows children and adults have a comparable expression of SARS-CoV-2 entry-related genes

A recent paper by researchers from China demonstrated comparable expression levels of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cell entry mediators in adults and children, suggesting that previously implied difference in viral-entry associated genes is likely not responsible for milder symptoms in children. The study is currently available on the medRxiv preprint server.

New data from Acucela's ACU-4429 Phase 2a trial on advanced dry AMD/geographic atrophy

Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that the first patient data from the ACU-4429 program were presented during a poster session at The Association for Research in Vision and Ophthalmology (ARVO) 2012 Annual Meeting.

Researchers demonstrate potential of new PET tracer for imaging prostate cancer

In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the University of Michigan demonstrate the potential of a new PET tracer, Carbon-11 labeled sarcosine (11C-sarcosine), for imaging prostate cancer, and set the stage for its possible use in monitoring other cancers.

Read more News

› Verified 6 days ago


Internal Medicine in Alexandria, VA

Alexandria Primary Care Associates
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 1500 N Beauregard St Ste 110, Alexandria, VA 22311
Phone: 703-370-9002    Fax: 703-370-2849
Franconia Internists, Pc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 5115 Franconia Rd, Alexandria, VA 22310
Phone: 703-660-0026    Fax: 703-922-4253
Bradlee Family Health Center
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 3541 W Braddock Rd, 101, Alexandria, VA 22302
Phone: 703-379-6020    Fax: 703-820-8799
Rediclinic Of Va, Llc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 7100 Silver Lake Blvd, Alexandria, VA 22315
Phone: 713-335-1731    Fax: 713-358-4881
Avicenna Clinic
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 5100 Leesburg Pike Ste 101, Alexandria, VA 22302
Phone: 703-705-9500    Fax: 703-417-9051
First Step Family Care, Llc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 3303 Duke Street, Alexandria, VA 22314
Phone: 703-212-6644    Fax: 703-212-6619
Ahmed Elebiary Md, Llc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 900 Virginia Ave, Alexandria, VA 22302
Phone: 703-705-9500    Fax: 571-685-2016

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.